Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-009657
Filing Date
2023-01-18
Accepted
2023-01-17 19:24:01
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d437944ds3.htm S-3 400726
2 EX-4.4 d437944dex44.htm EX-4.4 264263
3 EX-4.5 d437944dex45.htm EX-4.5 277411
4 EX-5.1 d437944dex51.htm EX-5.1 15311
5 EX-23.1 d437944dex231.htm EX-23.1 1592
6 EX-23.2 d437944dex232.htm EX-23.2 1572
7 EX-FILING FEES d437944dexfilingfees.htm EX-FILING FEES 55245
8 GRAPHIC g437944g0113103858731.jpg GRAPHIC 2747
9 GRAPHIC g437944g42h71.jpg GRAPHIC 56510
10 GRAPHIC g437944g51x49.jpg GRAPHIC 56039
  Complete submission text file 0001193125-23-009657.txt   1168731
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269272 | Film No.: 23532584
SIC: 2834 Pharmaceutical Preparations